Registered number
09591401
Year end:
31 May 2025
SARWAR ONCOLOGY LIMITED
UNAUDITED FILLETED ACCOUNTS
FOR THE YEAR
ENDED 31 MAY 2025

SARWAR ONCOLOGY LIMITED
Registered number: | 09591401
Balance Sheet
as at 31 May 2025
Notes |  |  | 2025 |  |  | 2024
|  |  |  | £ |  |  | £
FIXED ASSETS
Tangible assets | 3 |  |  | 1,141 |  |  | 273
CURRENT ASSETS
Debtors | 4 |  | 29,826 |  |  | 31,872
Cash at bank and in hand |  |  | 331,393 |  |  | 277,581
|  |  | 361,219 |  |  | 309,453
CREDITORS: amounts falling due within one year | 5 |  | (15,597) |  |  | (15,234)
NET CURRENT ASSETS |  |  |  | 345,622 |  |  | 294,219
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  |  | 346,763 |  |  | 294,492
Provisions for liabilities |  |  |  | (216) |  |  | (51)
NET ASSETS |  |  |  | £ 346,547 |  |  | £ 294,441
CAPITAL AND RESERVES
Called up share capital |  |  |  | 1 |  |  | 1
Profit and loss account |  |  |  | 346,546 |  |  | 294,440
SHAREHOLDER'S FUNDS |  |  |  | £ 346,547 |  |  | £ 294,441
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account is not delivered to Companies House.
Dr M N Sarwar
Director
Approved by the board on 18 May 2026

SARWAR ONCOLOGY LIMITED
Notes to the Accounts
for the year ended 31 May 2025
1 | ACCOUNTING POLICIES
| Basis of preparation
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
| Turnover
| Turnover is measured at the fair value of the consideration receivable, net of discounts and value added taxes. Turnover from the sale of any goods is recognised when goods are delivered and legal title has passed.
| Tangible fixed assets
| Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
| Office equipment | 25% p.a. on a reducing balance basis
| Deferred taxation
| Full provision is made for deferred taxation resulting from timing differences between the recognition of gains and losses in the accounts and their recognition for tax purposes. Deferred taxation is calculated on a non-discounted basis at the tax rates which are expected to apply in the periods when the timing differences are expected to reverse.
2 | EMPLOYEES | 2025 |  | 2024
|  |  |  |  |  | Number |  | Number
| Average number of persons employed by the company
| (excluding directors with no specific service contract) | - |  | -

SARWAR ONCOLOGY LIMITED
Notes to the Accounts
for the year ended 31 May 2025
3 | TANGIBLE FIXED ASSETS
|  |  |  |  |  |  |  | Office Equipment
|  |  |  |  |  |  |  | £
| Cost
| At 1 June 2024 | 1,532
| Additions | 1,248
| At 31 May 2025 | 2,780
| Depreciation
| At 1 June 2024 | 1,259
| Charge for the year | 380
| At 31 May 2025 | 1,639
| Net book value
| At 31 May 2025 | £ 1,141
| At 31 May 2024 | £ 273
4 | DEBTORS | 2025 |  | 2024
|  |  |  |  |  | £ |  | £
| Trade debtors | 8,442 |  | 8,185
| Director's loan account | 15,796 |  | 17,194
| Other debtors | 5,588 |  | 6,493
|  |  |  |  |  | £ 29,826 |  | £ 31,872
| Amounts due after more than one year included above | £ 5,134 |  | £ 5,588
5 | CREDITORS: amounts falling due within one year | 2025 |  | 2024
|  |  |  |  |  | £ |  | £
| Trade creditors | 306 |  | 2,408
| Corporation tax | 13,431 |  | 10,966
| Other creditors | 1,860 |  | 1,860
|  |  |  |  |  | £ 15,597 |  | £ 15,234

SARWAR ONCOLOGY LIMITED
Notes to the Accounts
for the year ended 31 May 2025
6 | LOANS TO DIRECTORS
| Description and conditions | B/fwd |  | Paid |  | Repaid |  | C/fwd
|  | £ |  | £ |  | £ |  | £
| Dr M N Sarwar
| Temporary loan with interest at the official rate applied to beneficial loans | 17,194 |  | - |  | (1,398) |  | 15,796
|  | £ 17,194 |  | £ - |  | £ (1,398) |  | £ 15,796
7 | CONTROLLING PARTY
| At the date of approval of these accounts Dr M N Sarwar controls the company by virtue of his holding 100% of the issued share capital.
8 | OTHER INFORMATION
| Sarwar Oncology Limited is a private company limited by shares and incorporated in England. Its registered office is:
| Titsey Estate Office
| Pilgrims Lane
| Oxted
| Surrey
| RH8 0SE
| The accounts are for the individual company and are presented in Sterling which is the functional currency of the company.

SARWAR ONCOLOGY LIMITED 09591401 false 2024-06-01 2025-05-31 2025-05-31 VT Final Accounts February 2026 Dr M N Sarwar No description of principal activity 09591401 2023-06-01 2024-05-31 09591401 core:WithinOneYear 2024-05-31 09591401 core:ShareCapital 2024-05-31 09591401 core:RetainedEarningsAccumulatedLosses 2024-05-31 09591401 core:AfterOneYear 2024-05-31 09591401 2024-06-01 2025-05-31 09591401 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 09591401 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 09591401 bus:Director40 2024-06-01 2025-05-31 09591401 core:PlantMachinery 2024-06-01 2025-05-31 09591401 bus:Director1 2024-06-01 2025-05-31 09591401 bus:Director1 1 2024-06-01 2025-05-31 09591401 countries:England 2024-06-01 2025-05-31 09591401 bus:FRS102 2024-06-01 2025-05-31 09591401 bus:FilletedAccounts 2024-06-01 2025-05-31 09591401 2025-05-31 09591401 core:WithinOneYear 2025-05-31 09591401 core:ShareCapital 2025-05-31 09591401 core:RetainedEarningsAccumulatedLosses 2025-05-31 09591401 core:PlantMachinery 2025-05-31 09591401 core:AfterOneYear 2025-05-31 09591401 bus:Director1 1 2025-05-31 09591401 2024-05-31 09591401 core:PlantMachinery 2024-05-31 09591401 bus:Director1 1 2024-05-31 iso4217:GBP xbrli:pure